Direkt zum Inhalt
Merck
  • Aldicarb poisoning. A case report with prolonged cholinesterase inhibition and improvement after pralidoxime therapy.

Aldicarb poisoning. A case report with prolonged cholinesterase inhibition and improvement after pralidoxime therapy.

Archives of internal medicine (1994-01-24)
J L Burgess, J N Bernstein, K Hurlbut
ZUSAMMENFASSUNG

Aldicarb is the most potent of the commercially available carbamate pesticides and is an unusual source of acute human poisonings. We present the case of a 43-year-old man exposed to aldicarb who developed severe cholinergic symptoms and progressive weakness requiring intubation for 5 days. Both his red blood cell cholinesterase and plasma pseudocholinesterase levels were depressed for a minimum of 44 hours. He demonstrated neuromuscular improvement concurrent with pralidoxime administration. The pertinent medical literature on aldicarb poisoning is reviewed.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Supelco
Aldicarb, PESTANAL®, analytical standard